Jun 13, 2023 / 02:00PM GMT
Operator
Good morning, ladies and gentlemen, and thank you for standing by. Welcome to Theratechnologies' sudocetaxel zendusortide protocol update and ASCO presentation video conference call. (Operator Instructions) I would like to also remind everyone that this conference call is being recorded today, Tuesday, June 13, 2023 at 10 a.m. Eastern Time. I will now turn the call over to Mr. Paul Levesque, President and Chief Executive Officer. Mr. Levesque, please go ahead.
Paul Lévesque - Theratechnologies Inc. - President, CEO & Director
Good morning. I want to wish everyone a very warm welcome and hope that you are as excited as we are for today's event. Before we begin, I'd like to remind everyone that our remarks today contain forward-looking statements regarding Theratechnologies current and future plans, expectations and intentions with respect to future events. You can find the FLIs posted on the screen.
When we assumed that Thera's letter to shareholders in January of this year, it was with the objective to share our strategic direction
Theratechnologies Inc Investors & Analysts: Phase 1 Trial Update Transcript
Jun 13, 2023
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers